Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 80719

5 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 03, 2018
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Westminster Pharmaceuticals LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

5 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 5

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-156-04.

D-1178-2018
Recall number
D-1178-2018
Initiated
August 03, 2018
Classification
Class I
Status
Terminated
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
lack of process controls
Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Code information

Lot #: 15617VP03, 15617VP01, 15617VP-02, Exp 7/31/2019; 15617VP06, 15617VP05, Exp 11/30/2019; 15617VP04, 15618004, 15618002, Exp 12/31/2019; 15618009, 15618008, Exp 2/29/2020; 15618011, Exp 3/31/2020.

Distribution pattern

Nationwide in the USA and Puerto Rico

drug · product 2 of 5

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.

D-1179-2018
Recall number
D-1179-2018
Initiated
August 03, 2018
Classification
Class I
Status
Terminated
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
lack of process controls
Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Code information

Lot #: 15717VP-01, 15717VP-02, 15717VP-03, Exp 7/31/2019; 15717002, Exp 12/31/2019; 15718004, Exp 3/31/2020.

Distribution pattern

Nationwide in the USA and Puerto Rico

drug · product 3 of 5

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.

D-1180-2018
Recall number
D-1180-2018
Initiated
August 03, 2018
Classification
Class I
Status
Terminated
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
lack of process controls
Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Code information

Lot #: 15517VP01, 15517VP02, 15517VP03, Exp 8/31/2019; 15518001, Exp 12/31/2019; 15518002, Exp 3/31/2020.

Distribution pattern

Nationwide in the USA and Puerto Rico

drug · product 4 of 5

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.

D-1181-2018
Recall number
D-1181-2018
Initiated
August 03, 2018
Classification
Class I
Status
Terminated
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
lack of process controls
Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Code information

Lot #: 15917VP03, 15917VP02, 15917VP01, Exp 10/31/2019; 15918004, 15918003, 15918002, 15918001, Exp 12/31/2019; 15918VP03, 15918VP02, 15918VP01, 15918005, Exp 2/29/2020; 15918007, 15918006, Exp 3/31/2020.

Distribution pattern

Nationwide in the USA and Puerto Rico

drug · product 5 of 5

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.

D-1182-2018
Recall number
D-1182-2018
Initiated
August 03, 2018
Classification
Class I
Status
Terminated
Quantity
Unknown

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
lack of process controls
Potency or specification failure reason.potency_specification_failure · v1.0.0
Failed Content Uniformity Specifications

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Code information

Lot #: 15817VP-01, 15817VP-02, 15817VP-03, Exp 9/30/2019; 15818001, Exp 3/31/2020.

Distribution pattern

Nationwide in the USA and Puerto Rico

Field note

Send feedback

We'll only use this to respond to your feedback.